Takeda joins BaseLaunch to boost early-stage biotech ventures in Europe
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
The move strengthens GBL’s clinical-stage presence in the United States
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Angelini Ventures has already invested €125 million in 22 startups
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
Subscribe To Our Newsletter & Stay Updated